Estimaciones de analistas de Wall Street para Achieve Life Sciences, Inc. (ACHV): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-05 | $-0.20 | ||
| 2026-08-11 | $-0.80 | $-0.16 | -385.2% |
| 2026-05-12 | $-0.19 | $-0.30 | +36.7% |
| 2026-03-24 | $-0.28 | $-0.27 | -3.7% |
| 2025-11-06 | $-0.28 | $-0.24 | -16.7% |
| 2025-08-07 | $-0.37 | $-0.37 | +0.0% |
| 2025-05-13 | $-0.37 | $-0.37 | +0.0% |
| 2025-03-11 | $-0.36 | $-0.30 | -20.0% |
Ratios de valoración
| Precio / Valor contable | -48.65 |
| EV / EBITDA | -7.43 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $5.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | 0 | $282000 | $282000 | $254000 | $255000 | 0 | 0 | 0 | $229000 | $228000 |
| Beneficio Bruto | $5.1M | -$282000 | -$282000 | -$254000 | -$255000 | 0 | 0 | 0 | -$229000 | -$228000 |
| I+D | $14.8M | $3.1M | $5.9M | $9.7M | $6.9M | $24.0M | $30.1M | $15.8M | $22.8M | $23.0M |
| Generales y Administrativos | $8.9M | $3.5M | $6.9M | $6.9M | $7.6M | $9.1M | $10.7M | $11.4M | $16.3M | $31.9M |
| Gastos Operativos | $23.7M | $6.6M | $12.8M | $16.5M | $14.5M | $33.1M | $40.8M | $27.2M | $38.8M | $54.7M |
| Beneficio Operativo | -$21.2M | -$6.6M | -$12.8M | -$16.5M | -$14.8M | -$33.1M | -$40.8M | -$27.2M | -$39.1M | -$54.9M |
| EBITDA | -$19.9M | -$13.4M | -$12.4M | -$16.1M | -$14.5M | -$32.9M | -$40.3M | -$26.7M | -$37.4M | -$53.6M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | $1.8M | $2.9M | $2.2M | $819000 |
| Beneficio Antes de Impuestos | -$20.1M | -$13.6M | -$12.7M | -$16.4M | -$14.7M | -$33.2M | -$42.4M | -$29.8M | -$39.8M | -$54.6M |
| Impuestos | -$1.1M | -$3.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$20.1M | -$10.6M | -$12.7M | -$16.4M | -$14.7M | -$33.2M | -$42.4M | -$29.8M | -$39.8M | -$54.6M |
| BPA | $-1478.66 | $-441.47 | $-72.29 | $-39.15 | $-5.39 | $-4.05 | $-3.95 | $-1.50 | $-1.24 | $-1.25 |
| BPA Diluido | $-1474.98 | $-441.47 | $-72.29 | $-39.15 | $-5.39 | $-4.05 | $-3.95 | $-1.50 | $-1.24 | $-1.25 |
| Acciones en Circulación (Diluidas) | $13647 | $23972 | $175511 | $412320 | $2.7M | $8.1M | $10.6M | $19.8M | $32.1M | $43.6M |
Precio
| Precio | $7.42 |
| Capitalización | $762M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ALLO · ARCT · AVIR · CAPR · HUMA · IMRX · SGMT
Explorar sector: Healthcare · Biotechnology
Más secciones de ACHV: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones